title: Multimodality Therapy for Limited-Stage Small-Cell Lung Cancer.
abstract: Limited-stage small-cell lung cancer (SCLC) occurs in only one third of patients with SCLC, but it is potentially curable. Combined-modality therapy (chemotherapy and radiotherapy) has long been the mainstay of therapy for this condition, but more recent data suggest a role for surgery in early-stage disease. Prophylactic cranial irradiation seems to improve outcomes in patients who have responded to initial therapy. This review addresses the practical aspects of staging and treatment of patients with limited-stage SCLC.
authors: University of Nebraska Medical Center; and Veterans Administration Nebraska-Western Iowa Health Care System, Omaha, NE.
authors: Daniel
authors: D
authors: Almquist
authors: University of Nebraska Medical Center; and Veterans Administration Nebraska-Western Iowa Health Care System, Omaha, NE.
authors: Kailash
authors: K
authors: Mosalpuria
authors: University of Nebraska Medical Center; and Veterans Administration Nebraska-Western Iowa Health Care System, Omaha, NE aganti@unmc.edu.
authors: Apar Kishor
authors: AK
authors: Ganti
mesh_terms: D003131:Combined Modality Therapy; D019468:Disease Management; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D009367:Neoplasm Staging; D011292:Premedication; D011379:Prognosis; D012008:Recurrence; D019233:Retreatment; D055752:Small Cell Lung Carcinoma / Q000473:pathology* / Q000628:therapy*; D016896:Treatment Outcome